Human Tyrosine Kinase 2 Deficiency Reveals Its Requisite Roles in Multiple Cytokine Signals Involved in Innate and Acquired Immunity

Immunity

Volumn 25, Issue 5, 2006, Pages 745-755

  Minegishi, Yoshiyuki ^a   Saito, Masako ^a   Morio, Tomohiro ^a   Watanabe, Ken ^a   Agematsu, Kazunaga ^b   Tsuchiya, Shigeru ^c   Takada, Hidetoshi ^d   Hara, Toshiro ^d   Kawamura, Nobuaki ^e   Ariga, Tadashi ^e   Kaneko, Hideo ^f   Kondo, Naomi ^f   Tsuge, Ikuya ^g   Yachie, Akihiro ^h   Sakiyama, Yukio ⁱ   Iwata, Tsutomu ^j   Bessho, Fumio ^k   Ohishi, Tsutomu ^l   Joh, Kosuke ^l   Imai, Kohsuke ^m   Kogawa, Kazuhiro ^m   Shinohara, Miwa ⁿ   Fujieda, Mikiya ⁿ   Wakiguchi, Hiroshi ⁿ   Pasic, Srdjan ^o   Abinun, Mario ^p   Ochs, Hans D ^q   Renner, Eleonore D ^q,r   Jansson, Annette ^r   Belohradsky, Bernd H ^r   Metin, Ayse ^s   Shimizu, Norio ^a   Mizutani, Shuki ^a   Miyawaki, Toshio ^t   Nonoyama, Shigeaki ^m   Karasuyama, Hajime ^a   more..

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b SHINSHU UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f GIFU UNIVERSITY   (Japan)

^g FUJITA HEALTH UNIVERSITY   (Japan)

^h KANAZAWA UNIVERSITY   (Japan)

ⁱ TEINE KEIJINKAI HOSPITAL   (Japan)

^j TOKYO KASEI UNIVERSITY   (Japan)

^k KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^l SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^m NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

ⁿ KOCHI UNIVERSITY   (Japan)

^o Mother and Child Health Institute

^p NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^q UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^r LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^s Diskapi Children's Hospital   (Turkey)

^t UNIVERSITY OF TOYAMA   (Japan)

more..

Author keywords

MOLIMMUNO; SIGNALING

Indexed keywords

CYTOKINE; ENZYME; IMMUNOGLOBULIN E; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 6; TYROSINE KINASE 2; UNCLASSIFIED DRUG;

ACQUIRED IMMUNITY; ADULT; ARTICLE; ATOPIC DERMATITIS; CASE REPORT; CELL DIFFERENTIATION; ENZYME DEFICIENCY; FUNGUS; HELPER CELL; HOMOZYGOSITY; HUMAN; HUMAN CELL; HYPERIMMUNOGLOBULIN E SYNDROME; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION SENSITIVITY; INNATE IMMUNITY; MALE; MUTATION; MYCOBACTERIUM AVIUM; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TYROSINE KINASE 2 DEFICIENCY; VIRUS;

ADOLESCENT; ADULT; BASE SEQUENCE; CYTOKINES; FLOW CYTOMETRY; HUMANS; IMMUNITY, NATURAL; IMMUNOBLOTTING; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; JOB'S SYNDROME; MALE; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TYK2 KINASE;

EID: 33845897463     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2006.09.009     Document Type: Article

References (48)

1. Alexander W.S., and Hilton D.J. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu. Rev. Immunol. 22 (2004) 503-529
2. Altare F., Durandy A., Lammas D., Emile J.F., Lamhamedi S., Le Deist F., Drysdale P., Jouanguy E., Doffinger R., Bernaudin F., et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280 (1998) 1432-1435
3. Bacon C.M., McVicar D.W., Ortaldo J.R., Rees R.C., O'Shea J.J., and Johnston J.A. Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12. J. Exp. Med. 181 (1995) 399-404
4. Casanova J.L., and Abel L. The human model: a genetic dissection of immunity to infection in natural conditions. Nat. Rev. Immunol. 4 (2004) 55-66
5. Conley M.E., Rohrer J., Rapalus L., Boylin E.C., and Minegishi Y. Defects in early B-cell development: comparing the consequences of abnormalities in pre-BCR signaling in the human and the mouse. Immunol. Rev. 178 (2000) 75-90
6. de Jong R., Altare F., Haagen I.A., Elferink D.G., Boer T., van Breda Vriesman P.J., Kabel P.J., Draaisma J.M., van Dissel J.T., Kroon F.P., et al. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280 (1998) 1435-1438
7. Dupuis S., Jouanguy E., Al-Hajjar S., Fieschi C., Al-Mohsen I.Z., Al-Jumaah S., Yang K., Chapgier A., Eidenschenk C., Eid P., et al. Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency. Nat. Genet. 33 (2003) 388-391
8. Fieschi C., Bosticardo M., de Beaucoudrey L., Boisson-Dupuis S., Feinberg J., Santos O.F., Bustamante J., Levy J., Candotti F., and Casanova J.L. A novel form of complete IL-12/IL-23 receptor β1 deficiency with cell surface-expressed nonfunctional receptors. Blood 104 (2004) 2095-2101
9. Firmbach-Kraft I., Byers M., Shows T., Dalla-Favera R., and Krolewski J.J. tyk2, prototype of a novel class of non-receptor tyrosine kinase genes. Oncogene 5 (1990) 1329-1336
10. Gauzzi M.C., Barbieri G., Richter M.F., Uze G., Ling L., Fellous M., and Pellegrini S. The amino-terminal region of Tyk2 sustains the level of interferon alpha receptor 1, a component of the interferon α/β receptor. Proc. Natl. Acad. Sci. USA 94 (1997) 11839-11844
11. Grimbacher B., Holland S.M., Gallin J.I., Greenberg F., Hill S.C., Malech H.L., Miller J.A., O'Connell A.C., and Puck J.M. Hyper-IgE syndrome with recurrent infections-an autosomal dominant multisystem disorder. N. Engl. J. Med. 340 (1999) 692-702
12. Grimbacher B., Schaffer A.A., Holland S.M., Davis J., Gallin J.I., Malech H.L., Atkinson T.P., Belohradsky B.H., Buckley R.H., Cossu F., et al. Genetic linkage of hyper-IgE syndrome to chromosome 4. Am. J. Hum. Genet. 65 (1999) 735-744
13. Grimbacher B., Holland S.M., and Puck J.M. Hyper-IgE syndromes. Immunol. Rev. 203 (2005) 244-250
14. Happel K.I., Dubin P.J., Zheng M., Ghilardi N., Lockhart C., Quinton L.J., Odden A.R., Shellito J.E., Bagby G.J., Nelson S., and Kolls J.K. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 202 (2005) 761-769
15. Hart P.H., Jones C.A., and Finlay-Jones J.J. Monocytes cultured in cytokine-defined environments differ from freshly isolated monocytes in their responses to IL-4 and IL-10. J. Leukoc. Biol. 57 (1995) 909-918
16. Hoffmann K.F., Cheever A.W., and Wynn T.A. IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J. Immunol. 164 (2000) 6406-6416
17. Ihle J.N. Cytokine receptor signalling. Nature 377 (1995) 591-594
18. Karaghiosoff M., Neubauer H., Lassnig C., Kovarik P., Schindler H., Pircher H., McCoy B., Bogdan C., Decker T., Brem G., et al. Partial impairment of cytokine responses in Tyk2-deficient mice. Immunity 13 (2000) 549-560
19. Liu K.D., Gaffen S.L., and Goldsmith M.A. JAK/STAT signaling by cytokine receptors. Curr. Opin. Immunol. 10 (1998) 271-278
20. Macchi P., Villa A., Giliani S., Sacco M.G., Frattini A., Porta F., Ugazio A.G., Johnston J.A., Candotti F., O'Shea J.J., et al. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 377 (1995) 65-68
21. Metin A., Uysal G., Guven A., Unlu A., and Ozturk M.H. Tuberculous brain abscess in a patient with hyper IgE syndrome. Pediatr. Int. 46 (2004) 97-100
22. Minegishi Y., and Conley M.E. Negative selection at the pre-BCR checkpoint elicited by human mu heavy chains with unusual CDR3 regions. Immunity 14 (2001) 631-641
23. Minegishi Y., Coustan-Smith E., Wang Y.H., Cooper M.D., Campana D., and Conley M.E. Mutations in the human λ5/14.1 gene result in B cell deficiency and agammaglobulinemia. J. Exp. Med. 187 (1998) 71-77
24. Minegishi Y., Coustan-Smith E., Rapalus L., Ersoy F., Campana D., and Conley M.E. Mutations in Igα (CD79a) result in a complete block in B-cell development. J. Clin. Invest. 104 (1999) 1115-1121
25. Minegishi Y., Rohrer J., Coustan-Smith E., Lederman H.M., Pappu R., Campana D., Chan A.C., and Conley M.E. An essential role for BLNK in human B cell development. Science 286 (1999) 1954-1957
26. Muller M., Briscoe J., Laxton C., Guschin D., Ziemiecki A., Silvennoinen O., Harpur A.G., Barbieri G., Witthuhn B.A., Schindler C., et al. The protein tyrosine kinase JAK1 complements defects in interferon-α/β and -γ signal transduction. Nature 366 (1993) 129-135
27. Neubauer H., Cumano A., Muller M., Wu H., Huffstadt U., and Pfeffer K. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell 93 (1998) 397-409
28. Nosaka T., van Deursen J.M., Tripp R.A., Thierfelder W.E., Witthuhn B.A., McMickle A.P., Doherty P.C., Grosveld G.C., and Ihle J.N. Defective lymphoid development in mice lacking Jak3. Science 270 (1995) 800-802
29. Nosaka T., Kawashima T., Misawa K., Ikuta K., Mui A.L., and Kitamura T. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells. EMBO J. 18 (1999) 4754-4765
30. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., Vega F., Yu N., Wang J., Singh K., et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13 (2000) 715-725
31. O'Shea J.J., Gadina M., and Schreiber R.D. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 109 Suppl (2002) S121-S131
32. Parganas E., Wang D., Stravopodis D., Topham D.J., Marine J.C., Teglund S., Vanin E.F., Bodner S., Colamonici O.R., van Deursen J.M., et al. Jak2 is essential for signaling through a variety of cytokine receptors. Cell 93 (1998) 385-395
33. Park S.Y., Saijo K., Takahashi T., Osawa M., Arase H., Hirayama N., Miyake K., Nakauchi H., Shirasawa T., and Saito T. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity 3 (1995) 771-782
34. Pasic S., Lilic D., Pejnovic N., Vojvodic D., Simic R., and Abinun M. Disseminated Bacillus Calmette-Guerin infection in a girl with hyperimmunoglobulin E syndrome. Acta Paediatr. 87 (1998) 702-704
35. Ragimbeau J., Dondi E., Alcover A., Eid P., Uze G., and Pellegrini S. The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression. EMBO J. 22 (2003) 537-547
36. Renner E.D., Puck J.M., Holland S.M., Schmitt M., Weiss M., Frosch M., Bergmann M., Davis J., Belohradsky B.H., and Grimbacher B. Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J. Pediatr. 144 (2004) 93-99
37. Rodig S.J., Meraz M.A., White J.M., Lampe P.A., Riley J.K., Arthur C.D., King K.L., Sheehan K.C., Yin L., Pennica D., et al. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell 93 (1998) 373-383
38. Russell S.M., Tayebi N., Nakajima H., Riedy M.C., Roberts J.L., Aman M.J., Migone T.S., Noguchi M., Markert M.L., Buckley R.H., et al. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 270 (1995) 797-800
39. Seto Y., Nakajima H., Suto A., Shimoda K., Saito Y., Nakayama K.I., and Iwamoto I. Enhanced Th2 cell-mediated allergic inflammation in Tyk2-deficient mice. J. Immunol. 170 (2003) 1077-1083
40. Shaw M.H., Boyartchuk V., Wong S., Karaghiosoff M., Ragimbeau J., Pellegrini S., Muller M., Dietrich W.F., and Yap G.S. A natural mutation in the Tyk2 pseudokinase domain underlies altered susceptibility of B10.Q/J mice to infection and autoimmunity. Proc. Natl. Acad. Sci. USA 100 (2003) 11594-11599
41. Shaw M.H., Freeman G.J., Scott M.F., Fox B.A., Bzik D.J., Belkaid Y., and Yap G.S. Tyk2 negatively regulates adaptive Th1 immunity by mediating IL-10 signaling and promoting IFN-gamma-dependent IL-10 reactivation. J. Immunol. 176 (2006) 7263-7271
42. Shimoda K., Kato K., Aoki K., Matsuda T., Miyamoto A., Shibamori M., Yamashita M., Numata A., Takase K., Kobayashi S., et al. Tyk2 plays a restricted role in IFNα signaling, although it is required for IL-12-mediated T cell function. Immunity 13 (2000) 561-571
43. Stahl N., Boulton T.G., Farruggella T., Ip N.Y., Davis S., Witthuhn B.A., Quelle F.W., Silvennoinen O., Barbieri G., Pellegrini S., et al. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 βreceptor components. Science 263 (1994) 92-95
44. Takaoka A., Mitani Y., Suemori H., Sato M., Yokochi T., Noguchi S., Tanaka N., and Taniguchi T. Cross talk between interferon-γ and -α/β signaling components in caveolar membrane domains. Science 288 (2000) 2357-2360
45. Velazquez L., Fellous M., Stark G.R., and Pellegrini S. A protein tyrosine kinase in the interferon α/β signaling pathway. Cell 70 (1992) 313-322
46. Watford W.T., Hissong B.D., Bream J.H., Kanno Y., Muul L., and O'Shea J.J. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol. Rev. 202 (2004) 139-156
47. Wood P.M., Fieschi C., Picard C., Ottenhoff T.H., Casanova J.L., and Kumararatne D.S. Inherited defects in the interferon-gamma receptor or interleukin-12 signalling pathways are not sufficient to cause allergic disease in children. Eur. J. Pediatr. 164 (2005) 741-747
48. Wu C., Ferrante J., Gately M.K., and Magram J. Characterization of IL-12 receptor β1 chain (IL-12Rβ1)-deficient mice: IL-12Rβ1 is an essential component of the functional mouse IL-12 receptor. J. Immunol. 159 (1997) 1658-1665